Park, Haesuk
Lo-Ciganic, Wei-Hsuan
Huang, James
Wu, Yonghui
Henry, Linda
Peter, Joy
Sulkowski, Mark
Nelson, David R.
Funding for this research was provided by:
National Institute on Drug Abuse (K01DA04561)
University of Florida Informatics Institute and Clinical and Translational Science Institute
National Institutes of Health Midcareer Investigator (K24DA034621)
Article History
Received: 14 June 2022
Accepted: 19 October 2022
First Online: 27 October 2022
Competing interests
: HP received grant funding from Bristol-Myers Squibb/Pfizer Alliance American Thrombosis Investigator Initiated Research Program (ARISTA-USA). WL received research funding from Merck & Co. DRN received research grant support from AbbVie, Bristol-Myers Squibb, Gilead, Janssen, and Merck & Co; and owns stock in Target Pharma Solutions. All other authors declare no competing interests.